A case report shows effective disease control in psoriatic patients with bullous pemphigoid, suggesting a promising treatment approach.
For psoriatic patients who develop bullous pemphigoid, a rare yet serious complication, prompt initiation of combined glucocorticoid and methotrexate provides rapid disease control and sustained remission. This regimen serves as an effective steroid-sparing strategy, though long-term monitoring remains essential to manage recurrence risks during steroid taper.
No takes yet. Share an insight, caveat, or question.
Ma et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: